ECTRIMS 2024 | Barriers to the treatment of MS in the MENA region

Maya Zeineddine, PharmD, Lebanese American University, Byblos, Lebanon, discusses the barriers to treatment for multiple sclerosis (MS) in the Middle East and North Africa (MENA) region. She mentions the lack of accessibility to disease-modifying therapies (DMTs) and issues with continuous access to care as significant barriers. This interview took place at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2024) in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.